311 related articles for article (PubMed ID: 30248539)
21. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
22. Isosilybin regulates lipogenesis and fatty acid oxidation via the AMPK/SREBP-1c/PPARα pathway.
Liu X; Hu M; Ye C; Liao L; Ding C; Sun L; Liang J; Chen Y
Chem Biol Interact; 2022 Dec; 368():110250. PubMed ID: 36347319
[TBL] [Abstract][Full Text] [Related]
23. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
[TBL] [Abstract][Full Text] [Related]
24. Silibinin Ameliorates Fructose-induced Lipid Accumulation and Activates Autophagy in HepG2 Cells.
Li Y; Ren L; Song G; Zhang P; Yang L; Chen X; Yu X; Chen S
Endocr Metab Immune Disord Drug Targets; 2019; 19(5):632-642. PubMed ID: 30734689
[TBL] [Abstract][Full Text] [Related]
25. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
26. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
27. Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid.
Bai XP; Dong F; Yang GH; Zhang L
Lipids Health Dis; 2019 Apr; 18(1):89. PubMed ID: 30954075
[TBL] [Abstract][Full Text] [Related]
28. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
[TBL] [Abstract][Full Text] [Related]
29. Anti-Metabolic Syndrome Effects of Fucoidan from
Wang X; Shan X; Dun Y; Cai C; Hao J; Li G; Cui K; Yu G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31547311
[TBL] [Abstract][Full Text] [Related]
30. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
[TBL] [Abstract][Full Text] [Related]
31. The SRE Motif in the Human PNPLA3 Promoter (-97 to -88 bp) Mediates Transactivational Effects of SREBP-1c.
Liang H; Xu J; Xu F; Liu H; Yuan D; Yuan S; Cai M; Yan J; Weng J
J Cell Physiol; 2015 Sep; 230(9):2224-32. PubMed ID: 25655569
[TBL] [Abstract][Full Text] [Related]
32. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
34. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
35. [Expression of aquaporin 3 and aquaporin 9 is regulated by oleic acid through the PI3K/Akt and p38 MAPK signaling pathways].
Gu LY; Qiu LW; Chen XF; Lv L; Mei ZC
Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):753-8. PubMed ID: 24331633
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1-AMPK signaling pathway.
Yu JW; Sun LJ; Liu W; Zhao YH; Kang P; Yan BZ
Int J Infect Dis; 2013 Jul; 17(7):e539-45. PubMed ID: 23510538
[TBL] [Abstract][Full Text] [Related]
37. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
38. Tetrahydrocurcumin ameliorates free fatty acid-induced hepatic steatosis and improves insulin resistance in HepG2 cells.
Chen JW; Kong ZL; Tsai ML; Lo CY; Ho CT; Lai CS
J Food Drug Anal; 2018 Jul; 26(3):1075-1085. PubMed ID: 29976400
[TBL] [Abstract][Full Text] [Related]
39. [Protective effect of silibinin on islet β cells in C57BL/6J mice fed a highfat diet].
Chen K; Xu J; He H; Zhao L; Xiong J; Mo Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb; 40(2):165-70. PubMed ID: 25769325
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity.
Zhang Q; Yuan H; Zhang C; Guan Y; Wu Y; Ling F; Niu Y; Li Y
Diabetes Res Clin Pract; 2018 Aug; 142():363-373. PubMed ID: 29940201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
